NCT06746571Not yet recruiting
Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients
Source: ClinicalTrials.gov · Last updated 24 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Role of cbc indices in acute lymphoblastic leukemia patients to explore the prognostic role of them in prediction the response to induction chemotherapy
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 18 Dec 2024
- Start date
- 15 Jan 2025
- Primary completion date
- 15 Jan 2026
- Lead sponsor
- Sohag University
- NCT number
- NCT06746571
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 15 Jan 2025 to the primary completion date, 15 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- ALL on therapy
Other
- others malignanices
Who the study is looking for
- patients newly diagnosed ALL
Age in the registry: 5 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sohag University Hospital Coordinator of this site? Confirm its status | Sohag | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.